Fr. Tad Pacholczyk joins Joe Zalot to update listeners on the state of—and ethical implications of—contemporary issues in biomedical research. Topics include stem cell research, 3-parent embryos, and synthetic embryos.
Read MoreDr. Maureen Condic, Associate Professor of Neurobiology at the University of Utah School of Medicine, discusses (1) how science demonstrates that human life begins at conception, and (2) how recent scientific advances indicate that preborn children may exhibit consciousness, and experience pain, earlier than previously thought.
Read MoreDr. John Grabenstein joins Joe Zalot to discuss the Regeneron cocktail that President Donald Trump received as part of his treatment for COVID-19.
Read MoreNCBC President Joseph Meaney and Staff Ethicist John Di Camillo join Joe Zalot to discuss ethical challenges concerning COVID-19 vaccines.
Read MoreArchbishop Joseph Naumann (Kansas City, Kansas), chairman of the USCCB Committee on Pro-Life Activities, and Greg Schleppenbach, associate director of the USCCB’s Secretariat of Pro-Life Activities, join Joe Zalot to discuss the work of the Pro-Life Committee and the US bishops’ call for the development of an ethical COVID-19 vaccine.
Read MoreNCBC ethicist John A. DiCamillo joins the podcast to answer concerns about COVID-19 and ethical challenges to vaccine development.
Read MoreDr. Carr J. Smith traces the roots of what he describes as a decline in scientific credibility to the loss of abstract reasoning skills. He then examines the long-term effects of this trend on the scientific community, education, and the culture at large.
Read MorePsychologist James Beauregard talks about the challenge of defining human dignity and the divergent approaches proposed by Christian and postmodern thinkers.
Read MorePhysicist Thomas Sheahen probes the limit of science’s ability to interpret unobservable phenomena like the multiverse, suggesting techniques for reconciling empirical inquiry with qualitative aspects of reality.
Read MoreIn our second episode about CRISPR gene editing technology, tech entrepreneur Joe Chiarella asks who is guiding these new multi-billion-dollar companies and balancing the goals of researchers and product makers against the best interests of society.
Read MoreGeneticist Fr. Nicanor Austriaco discusses the science behind CRISPR gene editing technology and the challenges it presents to ethicists.
Read More